Long term outer retinal changes in central serous chorioretinopathy submitted to half-dose photodynamic therapy.

[1]  C. Boon,et al.  Photodynamic Therapy for Chorioretinal Diseases: A Practical Approach , 2020, Ophthalmology and Therapy.

[2]  R. Tadayoni,et al.  Topographic Variations of Choroidal Thickness in Healthy Eyes on Swept-Source Optical Coherence Tomography , 2020, Investigative ophthalmology & visual science.

[3]  R. Asaoka,et al.  ELONGATED PHOTORECEPTOR OUTER SEGMENT LENGTH AND PROGNOSIS OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY. , 2020, Retina.

[4]  Young-Hoon Park,et al.  Comparing effects of photodynamic therapy in central serous chorioretinopathy: full-dose versus half-dose versus half-dose-half-fluence , 2019, Graefe's Archive for Clinical and Experimental Ophthalmology.

[5]  M. Larsen,et al.  Central serous chorioretinopathy: Towards an evidence-based treatment guideline , 2019, Progress in Retinal and Eye Research.

[6]  Su-Qin Yu,et al.  Long-term Visual Outcomes and Causes of Vision Loss in Chronic Central Serous Chorioretinopathy. , 2019, Ophthalmology.

[7]  Y. Lei,et al.  The relationship between foveal outer nuclear layer thickness in the active and resolved phases of central serous chorioretinopathy treated with half-dose photodynamic therapy , 2019, BMC Ophthalmology.

[8]  C. Cheung,et al.  Pachychoroid disease , 2018, Eye.

[9]  Ibrahim Ozdemir,et al.  Outer nuclear layer thickness at the central fovea relation with symptom duration in central serous chorioretinopathy , 2018, International Ophthalmology.

[10]  A. Ferreras,et al.  Anatomical Retinal Changes after Photodynamic Therapy in Chronic Central Serous Chorioretinopathy , 2018, Journal of ophthalmology.

[11]  M. Abràmoff,et al.  DYSFUNCTIONAL AUTONOMIC REGULATION OF THE CHOROID IN CENTRAL SEROUS CHORIORETINOPATHY , 2017, Retina.

[12]  Nadeem Ali Dhirani,et al.  Long-term outcomes in half-dose verteporfin photodynamic therapy for chronic central serous retinopathy , 2017, Clinical ophthalmology.

[13]  Fern,et al.  Chronicity and Recurrence as Prognostic Factors in Central Serous Chorioretinopathy after Half-Dose Photodynamic Therapy , 2016 .

[14]  S. Sonoda,et al.  Structural analyses of choroid after half-dose verteporfin photodynamic therapy for central serous chorioretinopathy , 2016, British Journal of Ophthalmology.

[15]  S. Sivaprasad,et al.  Age, Sex, and Ethnic Variations in Inner and Outer Retinal and Choroidal Thickness on Spectral-Domain Optical Coherence Tomography. , 2015, American journal of ophthalmology.

[16]  Min Zhao,et al.  Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis , 2015, Progress in Retinal and Eye Research.

[17]  F. Behar-Cohen,et al.  PACHYCHOROID: An Inherited condition? , 2015, Retina.

[18]  Yong-Kyu Kim,et al.  Comparison of visual and anatomical outcomes of half-fluence and half-dose photodynamic therapy in eyes with chronic central serous chorioretinopathy , 2015, Graefe's Archive for Clinical and Experimental Ophthalmology.

[19]  Lei Chen,et al.  Evaluation of the effects of photodynamic therapy on chronic central serous chorioretinopathy based on the mean choroidal thickness and the lumen area of abnormal choroidal vessels. , 2014, Photodiagnosis and photodynamic therapy.

[20]  Joan W. Miller,et al.  Strain difference in photoreceptor cell death after retinal detachment in mice. , 2014, Investigative ophthalmology & visual science.

[21]  Jennifer I. Lim,et al.  Collaborative retrospective macula society study of photodynamic therapy for chronic central serous chorioretinopathy. , 2014, Ophthalmology.

[22]  C. Brandl,et al.  Choroidal thickness measurements during central serous chorioretinopathy treatment , 2014, International Ophthalmology.

[23]  Takaaki Hayashi,et al.  One-year results of reduced fluence photodynamic therapy for central serous chorioretinopathy: the outer nuclear layer thickness is associated with visual prognosis , 2013, Graefe's Archive for Clinical and Experimental Ophthalmology.

[24]  J. Figueira,et al.  Long-term chorioretinal changes after photodynamic therapy for chronic central serous chorioretinopathy , 2013, Graefe's Archive for Clinical and Experimental Ophthalmology.

[25]  A. Yoshida,et al.  Elevated levels of monocyte chemoattractant protein-1 in the aqueous humor after phacoemulsification. , 2012, Investigative ophthalmology & visual science.

[26]  Masanori Hangai,et al.  Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy. , 2012, Ophthalmology.

[27]  Tomohiro Iida,et al.  SUBFOVEAL CHOROIDAL THICKNESS IN FELLOW EYES OF PATIENTS WITH CENTRAL SEROUS CHORIORETINOPATHY , 2011, Retina.

[28]  R. Spaide,et al.  Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. , 2010, Ophthalmology.

[29]  L. Yannuzzi.  Central serous chorioretinopathy: a personal perspective. , 2010, American journal of ophthalmology.

[30]  R. Spaide,et al.  ENHANCED DEPTH IMAGING OPTICAL COHERENCE TOMOGRAPHY OF THE CHOROID IN CENTRAL SEROUS CHORIORETINOPATHY , 2009, Retina.

[31]  S. Kishi,et al.  Outer nuclear layer thickness at the fovea determines visual outcomes in resolved central serous chorioretinopathy. , 2009, American journal of ophthalmology.

[32]  Hum Chung,et al.  Prognostic factors related to photodynamic therapy for central serous chorioretinopathy , 2009, Graefe's Archive for Clinical and Experimental Ophthalmology.

[33]  C. Prünte,et al.  Central serous chorioretinopathy , 2008, Acta ophthalmologica.

[34]  S. Kishi,et al.  Elongation of photoreceptor outer segment in central serous chorioretinopathy. , 2008, American journal of ophthalmology.

[35]  C. Valmaggia,et al.  Photodynamic Therapy in the Treatment of Chronic Central Serous Chorioretinopathy , 2006, Klinische Monatsblatter fur Augenheilkunde.

[36]  Michael D. Ober,et al.  Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy. , 2005, Ophthalmology.

[37]  G. Ravera,et al.  The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy. , 2005, American journal of ophthalmology.

[38]  D. Boyer,et al.  Chronic central serous chorioretinopathy: photodynamic therapy. , 2004, American journal of ophthalmology.

[39]  J. Castro-Correia,et al.  Long-term follow-up of central serous retinopathy in 150 patients , 2004, Documenta Ophthalmologica.

[40]  T. Lai,et al.  Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level , 2003, The British journal of ophthalmology.

[41]  T. Lai,et al.  Treatment of choroidal neovascularization in central serous chorioretinopathy by photodynamic therapy with verteporfin. , 2003, American journal of ophthalmology.

[42]  G. Peyman,et al.  Ocular photodynamic therapy for serous macular detachment in the diffuse retinal pigment epitheliopathy variant of idiopathic central serous chorioretinopathy. , 2003, American journal of ophthalmology.

[43]  J. Slakter,et al.  INDOCYANINE GREEN ANGIOGRAPHY‐GUIDED PHOTODYNAMIC THERAPY FOR TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY: A Pilot Study , 2003, Retina.

[44]  T. Hikichi,et al.  Features of abnormal choroidal circulation in central serous chorioretinopathy , 2003, The British journal of ophthalmology.

[45]  M. Parodi,et al.  Photodynamic therapy in chronic central serous chorioretinopathy. , 2003, Retina.

[46]  Ursula Schmidt-Erfurth,et al.  Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes , 2002, Graefe’s Archive for Clinical and Experimental Ophthalmology.

[47]  M. Larsen,et al.  Retinal atrophy in idiopathic central serous chorioretinopathy. , 2002, American journal of ophthalmology.

[48]  Timothy G Murray,et al.  FACTORS ASSOCIATED WITH REDUCED VISUAL ACUITY DURING LONG-TERM FOLLOW-UP OF PATIENTS WITH IDIOPATHIC CENTRAL SEROUS CHORIORETINOPATHY , 2002, Retina.

[49]  M. Takeda,et al.  [Study of choroidal vascular lesions in central serous chorioretinopathy using indocyanine green angiography]. , 1997, Nippon Ganka Gakkai zasshi.

[50]  J. Flammer,et al.  Choroidal capillary and venous congestion in central serous chorioretinopathy. , 1996, American journal of ophthalmology.

[51]  J. Slakter,et al.  INDOCYANINE GREEN VIDEOANGIOGRAPHY OF OLDER PATIENTS WITH CENTRAL SEROUS CHORIORETINOPATHY , 1996, Retina.

[52]  A. Ho,et al.  Digital indocyanine green videoangiography of central serous chorioretinopathy , 1994 .